These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8277796)
21. [Hepatitis C virus antibody in the serum of blood donors]. Barna TK; Ozsvár Z; Szendrényi V; Gál G Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664 [TBL] [Abstract][Full Text] [Related]
22. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV. Minz M; Sharma A; Das A; Chawla Y Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242 [TBL] [Abstract][Full Text] [Related]
23. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients. Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955 [TBL] [Abstract][Full Text] [Related]
24. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
25. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. Panigrahi AK; Panda SK; Dixit RK; Rao KV; Acharya SK; Dasarathy S; Nanu A J Med Virol; 1997 Mar; 51(3):167-74. PubMed ID: 9139079 [TBL] [Abstract][Full Text] [Related]
26. Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. Hu YW; Al-Moslih MI; Al Ali MT; Uzicanin S; Perkins H; Yi QL; Rahimi Khameneh S; Wu J; Brown EG J Med Virol; 2008 Feb; 80(2):365-71. PubMed ID: 18098140 [TBL] [Abstract][Full Text] [Related]
27. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298 [TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Kashef S; Karimi M; Amirghofran Z; Ayatollahi M; Pasalar M; Ghaedian MM; Kashef MA Int J Lab Hematol; 2008 Feb; 30(1):11-6. PubMed ID: 18190462 [TBL] [Abstract][Full Text] [Related]
29. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy]. Fujiyama S; Tanaka M Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668 [TBL] [Abstract][Full Text] [Related]
30. GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups. Desai MM; Pal RB; Banker DD Transfus Apher Sci; 2004 Apr; 30(2):111-7. PubMed ID: 15062748 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
32. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics. Bhattacharya DK; Bhattacharjee S; De M; Lahiri P Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels]. Kaşifoğlu N; Us T; Akgün Y Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074 [TBL] [Abstract][Full Text] [Related]
35. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy. Elia GF; Magnani G; Belli L; Formentini A; Iacono S; Marchelli S; Pincolini S; Lecchini R; Bernuzzi G; Fiaccadori F Infection; 1991; 19(5):336-9. PubMed ID: 1666064 [TBL] [Abstract][Full Text] [Related]
36. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. Wonke B; Hoffbrand AV; Brown D; Dusheiko G J Clin Pathol; 1990 Aug; 43(8):638-40. PubMed ID: 2119395 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. Khalifa AS; Mitchell BS; Watts DM; el-Samahy MH; el-Sayed MH; Hassan NF; Jennings GB; Hibbs RG; Corwin AL Am J Trop Med Hyg; 1993 Sep; 49(3):316-21. PubMed ID: 7690525 [TBL] [Abstract][Full Text] [Related]